methylprednisolone has been researched along with Angioma, Cavernous in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (14.29) | 18.7374 |
1990's | 1 (14.29) | 18.2507 |
2000's | 5 (71.43) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Mehta, M | 1 |
Özsoylu, Ş | 2 |
Taylor, I | 1 |
Dourmishev, AL; Dourmishev, LA | 1 |
Pai, KS; Park, MS; Yu, JE | 1 |
Gürgey, A; Irken, G; Ozsoylu, S | 1 |
7 other study(ies) available for methylprednisolone and Angioma, Cavernous
Article | Year |
---|---|
Drug incompatibility with methylprednisolone.
Topics: Adult; Anti-Inflammatory Agents; Antihypertensive Agents; Diltiazem; Drug Incompatibility; Hemangioma, Cavernous; Humans; Intraoperative Period; Male; Methylprednisolone; Spinal Cord Injuries; Spinal Cord Neoplasms | 2008 |
Megadose methylprednisolone for Kasabach-Merritt syndrome.
Topics: Glucocorticoids; Hemangioma, Cavernous; Humans; Infant; Methylprednisolone; Skin Neoplasms; Syndrome; Thrombocytopenia | 2003 |
Cavernous hemangioma. Reversible posterior leukoencephalopathy syndrome.
Topics: Adult; Azathioprine; Diabetes Mellitus, Type 1; Diffusion Magnetic Resonance Imaging; Female; Hemangioma, Cavernous; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Magnetic Resonance Imaging; Methylprednisolone; Myasthenia Gravis; Occipital Lobe; Peripheral Vascular Diseases; Posterior Leukoencephalopathy Syndrome; Seizures | 2003 |
Craniofacial cavernous hemangioma: succesful treatment with methylprednisolone.
Topics: Craniofacial Abnormalities; Female; Glucocorticoids; Hemangioma, Cavernous; Humans; Infant; Methylprednisolone; Treatment Outcome | 2005 |
Congenital cavernous hemangioma exhibiting subcutaneous fat necrosis.
Topics: Fat Necrosis; Female; Glucocorticoids; Hemangioma, Cavernous; Hemostasis, Surgical; Humans; Infant, Newborn; Methylprednisolone | 2008 |
Megadose methylprednisolone therapy for Kasabach-Merritt syndrome.
Topics: Glucocorticoids; Hemangioma, Cavernous; Humans; Infant; Infant, Newborn; Methylprednisolone; Syndrome; Thrombocytopenia | 1996 |
High dose intravenous methylprednisolone for Kassabach-Merritt syndrome.
Topics: Anemia, Hemolytic; Blood Coagulation Disorders; Female; Hemangioma, Cavernous; Humans; Infant; Infusions, Intravenous; Methylprednisolone; Syndrome; Thrombocytopenia | 1989 |